Tech Company Financing Transactions

PineTree Therapeutics Funding Round

PineTree Therapeutics, based in Cambridge, secured $23.5 million from DSC Investment, InterVest and JCurve Investment.

Transaction Overview

Announced On
6/8/2022
Transaction Type
Venture Equity
Amount
$23,500,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to advance their oncology and viral diseases platforms.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
c/o Ipsen Innovation Center 650 East Kendall Street
Cambridge, MA 02142
USA
Phone
Undisclosed
Email Address
Overview
PineTree Therapeutics Inc. is a preclinical stage Biotechnology company that is pioneering the development of disruptive therapies in Oncology and Infectious Diseases.
Profile
PineTree Therapeutics LinkedIn Company Profile
Social Media
PineTree Therapeutics Company Twitter Account
Company News
PineTree Therapeutics News
Facebook
PineTree Therapeutics on Facebook
YouTube
PineTree Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Clemens Reinshagen
  Clemens Reinshagen LinkedIn Profile  Clemens Reinshagen Twitter Account  Clemens Reinshagen News  Clemens Reinshagen on Facebook
Chief Executive Officer
Hojuhn Song
  Hojuhn Song LinkedIn Profile  Hojuhn Song Twitter Account  Hojuhn Song News  Hojuhn Song on Facebook
Chief Financial Officer
Bennett Goldstein
  Bennett Goldstein LinkedIn Profile  Bennett Goldstein Twitter Account  Bennett Goldstein News  Bennett Goldstein on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/8/2022: Finch API venture capital transaction
Next: 6/8/2022: Valkyrie Investments venture capital transaction

 

Share this article

 


News on VC Transactions

We record tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary